# Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus

> **NCT01954147** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Diabetes Care Center of Nanjing Military Command** · enrollment: 100 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** GLP-1
- **BIOLOGICAL:** SC
- **OTHER:** Standard Medical Treatment

## Key facts

- **NCT ID:** NCT01954147
- **Lead sponsor:** Diabetes Care Center of Nanjing Military Command
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2014-10
- **Final completion:** 2015-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01954147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01954147, "Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01954147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*